NDC 72626-2601 – Ledipasvir and Sofosbuvir
Ledipasvir 90 mg/1; Sofosbuvir 400 mg/1 · Tablet, Film Coated · Oral
Product NDC72626-2601
Product details
- Brand name
- Ledipasvir and Sofosbuvir
- Generic name
- Ledipasvir and Sofosbuvir
- Labeler
- Asegua Therapeutics LLC
- Dosage form
- Tablet, Film Coated
- Route
- Oral
- Marketing category
- NDA AUTHORIZED GENERIC · NDA205834
- Marketed since
- January 1, 2019
- Listing expires
- December 31, 2026
- Pharmacologic class
- Hepatitis C Virus NS5A Inhibitor; Hepatitis C Virus Nucleotide Analog NS5B Polymerase Inhibitor
Active ingredients
- Ledipasvir 90 mg/1
- Sofosbuvir 400 mg/1
Uses, dosage, side effects and warnings for Ledipasvir and Sofosbuvir →
Package NDC codes (1)
| Package NDC | Description | Since |
|---|---|---|
| 72626-2601-1 | 2 BLISTER PACK in 1 CARTON (72626-2601-1) / 14 TABLET, FILM COATED in 1 BLISTER PACK | Jan 1, 2019 |